杨宁介入医学网

 

Cordis has launched a new vascular closure device in 2010 and completed its portfolio from “Stick to Seal” with this exciting product. EXOSEALTM is combining an easy-to-use functionality with a trusted bioabsorbable plug and a precise extravascular positioning.
The ExoSeal™ Vascular Closure Device incorporates key advancements including the use of the Polyglycolic Acid Plug, two visual indicators to moderate control of the device and lockout features to reduce the risk of complications. The device is designed for ease of use, reducing the number of components and deployment steps.
The EXOSEALTM clinical study ‘ECLIPSE’ recorded no adverse clinical events and achieved a level of safety comparable to manual compression while significantly reducing time to ambulation.